Beef Product Directory

Keep Cydectin out of reach of children.

FOR ALL PRODUCTS: The label contains complete use information, including cautions and warnings. Always read, understand and follow the label, and use directions.

Micotil

Caution: 

Not for animals intended for breeding.

Indications:

Micotil is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, and for the control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica.

IMPORTANT SAFETY INFORMATION:

Before using this product, it is important to read the entire product insert, including the boxed human warning. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for human use. Injection of this drug in humans has been associated with fatalities. Keep out of reach of children. Administer only with a tube-fed safety syringe. Do not use in automatically powered syringes, single-use syringes, or other delivery devices. Exercise extreme caution to avoid accidental self-injection. In case of human injection, consult a physician immediately and apply ice or cold pack to injection site while avoiding direct contact with the skin. Avoid contact with eyes. Always use proper drug handling procedures to avoid accidental self-injection. Consult your veterinarian on the safe handling and use of all injectable products prior to administration. For use in cattle or sheep only. Inject subcutaneously. Injection of this antibiotic has been shown to be fatal in swine and non-human primates, and may be fatal in horses and goats. Do not use in lambs less than 15 kg body weight. Do not use in female dairy cattle 20 months of age or older. Use in lactating dairy cattle or sheep may cause milk residues. The following adverse reactions have been reported: in cattle: injection site swelling and inflammation, lameness, collapse, anaphylaxis/anaphylactoid reactions, decreased food and water consumption, and death; in sheep: dyspnea and death. Micotil has a pre-slaughter withdrawal time of 42 days.

Baytril 100

Cautions:

Not for human use. Keep out of reach of children. For subcutaneous use in beef cattle and non-lactating dairy cattle.

Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals.

Indications:

Cattle – Single-Dose Therapy: Baytril 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.

Cattle – Multiple-Day Therapy: Baytril 100 is indicated for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle.

Directions for use:

Single-Dose Therapy (BRD Treatment): Administer, by subcutaneous injection, a single dose of 7.5-12.5 mg/kg of body weight (3.4-5.7 mL/100 lbs.).

Multiple-Day Therapy (BRD Treatment): Administer daily, a subcutaneous dose of 2.5-5 mg/kg of body weight (1.1-2.3 mL/100 lbs.).

Treatment should be repeated at 24-hour intervals for three days. Additional treatments may be given on days 4 and 5 to animals that have shown clinical improvement but not total recovery.

Baytril 100 provides flexible subcutaneous injection dosages and durations of therapy.

Do not use in female dairy cattle 20 months of age or older or in calves to be processed for veal.

Talk with your veterinarian to learn more. 

COMPONENT TE-IS with TYLAN IMPORTANT SAFETY INFORMATION:

INDICATIONS:

For increased rate of weight gain and improved feed efficiency in growing beef steers fed in confinement for slaughter.

Not approved for repeated implantation (re-implantation) with this or any other cattle ear implant in growing beef steers fed in confinement for slaughter.  Safety and effectiveness following reimplantation have not been evaluated.

DIRECTIONS FOR USE: Administer one dose in the ear subcutaneously according to label directions.

CAUTION:  Federal law restricts this drug to use by or on the order of a licensed veterinarian.

COMPONENT TE-IH with TYLAN IMPORTANT SAFETY INFORMATION:

INDICATIONS:

For increased rate of weight gain and improved feed efficiency in growing beef heifers fed in confinement for slaughter.

Not approved for repeated implantation (re-implantation) with this or any other cattle ear implant in growing beef heifers fed in confinement for slaughter.  Safety and effectiveness following reimplantation have not been evaluated.

DIRECTIONS FOR USE:  Administer one dose in the ear subcutaneously according to label directions.

CAUTION: Federal law restricts this drug to use by or on the order of licensed veterinarian.

COMPONENT E-C with TYLAN IMPORTANT SAFETY INFORMATION:

INDICATION:

For increased rate of weight gain in beef calves 45 days of age and older and weighing up to 400 lbs.

This implant is not approved for repeated implantation (re-implantation) with this or any other cattle ear implant as safety and effectiveness has not been evaluated.

DIRECTIONS FOR USE: Administer one dose in the ear subcutaneously according to label directions.

CAUTION:  Federal law restricts this drug to use by or on the order of a licensed veterinarian.

COMPONENT TE-G with Tylan IMPORTANT SAFETY INFORMATION:

INDICATION:

For increased rate of weight gain in growing beef steers and heifers on pasture (stocker, feeder, and slaughter).

Not approved for repeated implantation (re-implantation) with this or any other cattle ear implant in growing beef steers and heifers on pasture (stocker, feeder, and slaughter).  Safety and effectiveness following reimplantation have not been evaluated. 

DIRECTIONS FOR USE:  Administer one dose in the ear subcutaneously according to label directions.

CAUTION:  Federal law restricts this drug to use by or on the order of a licensed veterinarian.

COMPONENT TE-200 with Tylan IMPORTANT SAFETY INFORMATION:

INDICATIONS:

For increased rate of weight gain and improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter.

Not approved for repeated implantation (re-implantation) with this or any other cattle ear implant in growing beef steers and heifers fed in confinement for slaughter.  Safety and effectiveness following reimplantation have not been evaluated.

DIRECTIONS FOR USE: Administer one dose in the ear subcutaneously according to label directions.

CAUTION:  Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Compudose

Directions for use:

Administer one dose in the ear subcutaneously according to label directions.

Encore

Directions for use:

Administer one dose in the ear subcutaneously according to label directions.

Experior

Cautions:

Not approved for use in breeding animals because safety and effectiveness have not been evaluated in these animals. Do not allow horses or other equines access to feed containing Experior. A decrease in dry matter intake may be noticed in some animals.

Indications:

For the reduction of ammonia gas emissions per pound of live weight and hot carcass weight in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed. 

Directions for use: 

Feed. 1.25 to 4.54 g/ton (1.39 to 5 ppm) of complete feed (90% dry matter basis) to provide 13-90 mg lubabegron/head/day continuously to beef steers and heifers fed in confinement for slaughter as sole ration during the Last 14 to 91 days on feed.

Ammonia gas emissions were measured for individual animals or small groups of animals held in environmentally controlled facilities. Based on existing information, reliable predictions of the reduction of ammonia gas emissions cannot be made on a herd, farm, or larger scale. Increased rate of weight gain, improved feed efficiency, and increased carcass leanness have not been demonstrated with this product.

HeifermaX

Indications:

HeifermaX 500: Heifers fed in confinement for slaughter
For increased rate of weight gain, improved feed efficiency and suppression of estrus (heat): Feed 0.5 to 2.0 lb/hd/d in a Type C medicated feed to provide 0.25 to 0.5 mg/hd/d.

HeifermaX 500: Heifers intended for breeding
For suppression of estrus (heat): Thoroughly mix HeifermaX in the supplement to provide 0.5 mg/hd/d of melengestrol acetate.

Increxxa

Cautions: 

Not for human use. Keep out of reach of children. Do not use in animals previously found to be hypersensitive to the drug. Increxxa has a pre-slaughter withdrawal time of 18 days. Do not use in female dairy cattle 20 months of age or older.

Indications:

Beef and Non-Lactating Dairy Cattle: Treatment of bovine respiratory disease (BRD) and control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. Treatment of infectious bovine keratoconjunctivitis (IBK) associated with M. bovis. Treatment of bovine foot rot (interdigital necrobacillosis) associated with F. necrophorum and P. levii.

Suckling Calves, Dairy Calves and Veal Calves: Treatment of BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.

Directions for use: 

In cattle, inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb) body weight. Do not inject more than 10 mL per injection site.

Optaflexx:

Caution:

Not for animals intended for breeding.

Directions for use:

Complete feed
For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter: Feed 8.2 to 24.6 g/ton of ractopamine hydrochloride (90% DM basis) continuously in a complete feed to provide 70 to 430 mg/hd/d for the last 28 to 42 days on feed.
For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter: Feed 9.8 to 24.6 g/ton of ractopamine hydrochloride (90% DM basis) continuously in a complete feed to provide 90 to 430 mg/hd/d for the last 28 to 42 days on feed.

Top dress
For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter: Feed 70 to 400 mg/hd/d of ractopamine hydrochloride (90% DM basis) continuously in a minimum of 1.0 lb/hd/d top dress Type C medicated feed (maximum 800 g/ton ractopamine hydrochloride) during the last 28 to 42 days on feed.

Carcass leanness effects are not an approved indication for use when feeding ractopamine by top dress feeding methods.

Ravap EC Livestock, Poultry, & Premise Insecticide Spray

Cautions: 

RESTRICTED USE PESTICIDE: Due to acute eye and dermal toxicity.  For retail sale to and use only by Certified Applicators or persons under their direct supervision and only for those uses covered by the Certified Applicator’s Certification.

Rumensin

Cautions:

Consumption by unapproved species or feeding undiluted may be toxic or fatal. Do not feed to veal calves.

Directions for use:

Growing beef steers and heifers fed in confinement for slaughter:

For improved feed efficiency: Feed 5 to 40 g/ton of monensin (90% DM basis) continuously in a complete feed to provide 50 to 480 mg/hd/day.

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii: Feed 10 to 40 g/ton (90% DM basis) to provide 0.14 to 0.42 mg/lb. of body weight/d, depending upon severity of challenge, up to a maximum of 480 mg/hd/day.

Growing beef steers and heifers on pasture (stocker, feeder and slaughter) or in a dry lot, and replacement beef and dairy heifers:

For increased rate of weight gain: Feed 50 to 200 mg/hd/day in at least 1.0 lb. of Type C Medicated Feed. Or, after the fifth day, feed 400 mg/hd/day every other day in 2.0 lbs. of Type C Medicated Feed. The Type C Medicated Feed must contain 15 to 400 g/ton of monensin (90% DM basis). Do not self-feed.

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii: Feed at a rate to provide 0.14 to 0.42 mg/lb. of body weight/day, depending upon the severity of challenge, up to a maximum of 200 mg/hd/day. The Type C Medicated Feed must contain 15 to 400 g/ton of monensin (90% DM basis).

Type C free-choice medicated feeds: All Type C free-choice medicated feeds containing Rumensin must be manufactured according to an FDA-approved formula/specification. When using a formula/specification published in the Code of Federal Regulations (CFR), a Medicated Feed Mill license is not required. Use of Rumensin in a proprietary formula/specification not published in the CFR requires prior FDA approval and a Medicated Feed Mill License.

Beef cows:

For improved feed efficiency when receiving supplemental feed: Feed continuously at a rate of 50 to 200 mg/hd/day. Cows on pasture or in dry lot must receive a minimum of 1.0 lb. of Type C medicated feed/hd/d. Do not self-feed.

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii: Feed at a rate of 0.14 to 0.42 mg/lb. of body weight/d, depending upon severity of challenge, up to a maximum of 200 mg/hd/day.

For calves (excluding veal calves):

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii: Feed at a rate of 0.14 to 1.00 mg/lb. of body weight/day, depending upon the severity of challenge, up to a maximum of 200 mg of monensin/hd/day. The monensin concentration in Type C medicated feed must be between 10 and 200 g/ton.

Tylan

Caution:

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Directions for use:

For reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes: Feed continuously at 8 to 10 g/ton of tylosin (90% DM basis) to provide 60 to 90 mg/hd/d.

Vapona Concentrate Insecticide

Cautions: 

RESTRICTED USE PESTICIDE: Due to the acute oral, acute dermal, primary eye and primary dermal toxicity.  For retail sale to and use only by Certified Applicators or persons under their direct supervision, and only for those uses covered by Certified Applicator's Certification.

Do not use Titanium^® BRSV 3, Titanium^® 3 LP, Titanium^® 3, Titanium^® IBR LP and Titanium^® IBR in pregnant cows or in calves nursing pregnant cows. Abortions may result.

Click to download Cydectin Dewormer Product Label.

Click to download Baytril 100 Product Label.

Agita, Benchmark, Clean-Up, Component, Compudose, Corathon, Cydectin, CyLence, Elector, Encore, Experior, HeifermaX, Increxxa, Master Guard, Micotil, Neporex, Nuplura, Optaflexx, Patriot, PenPoint, Permectrin, Ravap, Rumensin, Scour Bos, Titanium, Tylan, Vapona, Vira Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

Baytril is sold by Elanco or its affiliates and is not a Bayer product. The Baytril trademark is owned by Bayer and used under license. The Baytril and  QuickBayt trademarks are owned by Bayer and used under license.

Pradalex
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.  Not for use in humans.  Keep out of reach of children.  Avoid contact with eyes and skin.  Individuals with a history of hypersensitivity to quinolones should avoid this product.  Not for use in animals intended for breeding greater than 1 year of age because the effects of Pradalex on bovine reproductive performance, pregnancy, and lactation have not been determined.  Not for use in beef and dairy calves less than 2 months of age, and veal calves; a withdrawal period has not been established for this product in pre-ruminating calves.  Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders.  Mild to moderate inflammatory changes of the injection site may be seen in cattle treated with Pradalex.  See package insert for additional safety information.